105 related articles for article (PubMed ID: 25059758)
1. Pharmacological characterization of a highly selective and potent partial agonist of the MT₂ melatonin receptor.
Sakurai T; Koike T; Nakayama M
Pharmacology; 2014; 93(5-6):244-52. PubMed ID: 25059758
[TBL] [Abstract][Full Text] [Related]
2. 1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT₂-selective agonists.
Koike T; Hoashi Y; Takai T; Nakayama M; Yukuhiro N; Ishikawa T; Hirai K; Uchikawa O
J Med Chem; 2011 May; 54(9):3436-44. PubMed ID: 21473625
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.
Nishiyama K; Shintani Y; Hirai K; Yoshikubo S
J Pharmacol Exp Ther; 2009 Sep; 330(3):855-63. PubMed ID: 19556449
[TBL] [Abstract][Full Text] [Related]
4. New MT₂ Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists.
Boutin JA; Bonnaud A; Brasseur C; Bruno O; Lepretre N; Oosting P; Coumailleau S; Delagrange P; Nosjean O; Legros C
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28644418
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
[TBL] [Abstract][Full Text] [Related]
6. C-terminal domains within human MT1 and MT2 melatonin receptors are involved in internalization processes.
Sethi S; Adams W; Pollock J; Witt-Enderby PA
J Pineal Res; 2008 Sep; 45(2):212-8. PubMed ID: 18341518
[TBL] [Abstract][Full Text] [Related]
7. Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.
Landagaray E; Ettaoussi M; Duroux R; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
Eur J Med Chem; 2016 Feb; 109():360-70. PubMed ID: 26820449
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors.
Audinot V; Bonnaud A; Grandcolas L; Rodriguez M; Nagel N; Galizzi JP; Balik A; Messager S; Hazlerigg DG; Barrett P; Delagrange P; Boutin JA
Biochem Pharmacol; 2008 May; 75(10):2007-19. PubMed ID: 18384758
[TBL] [Abstract][Full Text] [Related]
9. O-linked melatonin dimers as bivalent ligands targeting dimeric melatonin receptors.
Karamitri A; Sadek MS; Journé AS; Gbahou F; Gerbier R; Osman MB; Habib SAM; Jockers R; Zlotos DP
Bioorg Chem; 2019 Apr; 85():349-356. PubMed ID: 30658234
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
Poissonnier-Durieux S; Ettaoussi M; Pérès B; Boutin JA; Audinot V; Bennejean C; Delagrange P; Caignard DH; Renard P; Berthelot P; Lesieur D; Yous S
Bioorg Med Chem; 2008 Sep; 16(18):8339-48. PubMed ID: 18778943
[TBL] [Abstract][Full Text] [Related]
11. Alternative Radioligands for Investigating the Molecular Pharmacology of Melatonin Receptors.
Legros C; Brasseur C; Delagrange P; Ducrot P; Nosjean O; Boutin JA
J Pharmacol Exp Ther; 2016 Mar; 356(3):681-92. PubMed ID: 26759496
[TBL] [Abstract][Full Text] [Related]
12. Characterization of substituted phenylpropylamides as highly selective agonists at the melatonin MT2 receptor.
Chan KH; Hu Y; Ho MK; Wong YH
Curr Med Chem; 2013; 20(2):289-300. PubMed ID: 23131177
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of substituted N-[3-(3-methoxyphenyl)propyl] amides as highly potent MT(2)-selective melatonin ligands.
Hu Y; Ho MK; Chan KH; New DC; Wong YH
Bioorg Med Chem Lett; 2010 Apr; 20(8):2582-5. PubMed ID: 20227878
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.
Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F
J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin receptor (MT1/MT2) ligands.
Koike T; Takai T; Hoashi Y; Nakayama M; Kosugi Y; Nakashima M; Yoshikubo S; Hirai K; Uchikawa O
J Med Chem; 2011 Jun; 54(12):4207-18. PubMed ID: 21568291
[TBL] [Abstract][Full Text] [Related]
16. 2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.
Zlotos DP; Attia MI; Julius J; Sethi S; Witt-Enderby PA
J Med Chem; 2009 Feb; 52(3):826-33. PubMed ID: 19193160
[TBL] [Abstract][Full Text] [Related]
17. Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells.
Witt-Enderby PA; Dubocovich ML
Mol Pharmacol; 1996 Jul; 50(1):166-74. PubMed ID: 8700109
[TBL] [Abstract][Full Text] [Related]
18. N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivity.
Markl C; Clafshenkel WP; Attia MI; Sethi S; Witt-Enderby PA; Zlotos DP
Arch Pharm (Weinheim); 2011 Oct; 344(10):666-74. PubMed ID: 21887801
[TBL] [Abstract][Full Text] [Related]
19. New melatonin (MT1/MT2) ligands: design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives.
Landagaray E; Ettaoussi M; Leclerc V; Traoré B; Perez V; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
Bioorg Med Chem; 2014 Feb; 22(3):986-96. PubMed ID: 24417958
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive properties of selective MT(2) melatonin receptor partial agonists.
López-Canul M; Comai S; Domínguez-López S; Granados-Soto V; Gobbi G
Eur J Pharmacol; 2015 Oct; 764():424-432. PubMed ID: 26162699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
